Advances in Direct, Functional, Non-Invasive Biomarkers; Athira’s Utilization of ERP P300

Time: 3:10 pm
day: Day One


• Adding direct, functional biomarkers to translation and interventional
trials to enhance predictiveness for pro-cognitive effects
• Utilizing highly sensitive latency changes in ERP P300 to monitor
cognitive status quantitatively over time
• Innovation in application of clinically established ERPs; how Athira‘s use
of ERP P300 in AD drug development reduces Phase 2 risk
• Initial interventional RCT results in AD to be presented